Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eric R. Kinzler
Observed names:
E. Kinzler,
Eric Kinzler,
Eric R Kinzler,
Eric R. Kinzler, PhD,
Kinzler, Eric R.
Observed institutions:
University of Wisconsin–Madison,
University of Colorado Boulder,
University of Colorado System,
Xenon Pharmaceuticals (Canada),
Nema Research (United States),
Kiniksa Pharmaceuticals (United States),
Intellectual Property Office
show all 7
ORCID:
0000-0001-6601-0699
Observed ORCID:
0000-0001-6601-0699
OpenAlex ID:
A5088188722
Characterization of Human Cytomegalovirus Glycoprotein-Induced Cell-Cell Fusion
2005
·
Eric R. Kinzler
, Teresa Compton
·
Journal of Virology
·
102
Tbx12, a novel T-box gene, is expressed during early stages of heart and retinal development
2000
·
Christian T Carson
, Eric R Kinzler
, et al.
·
Mechanisms of Development
·
44
PDF
Expression and reconstitution of the gH/gL/gO complex of human cytomegalovirus
2002
·
Eric R Kinzler
, Regan N Theiler
, et al.
·
Journal of Clinical Virology
·
25
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Drug Liking Study on a Novel Abuse-Deterrent Formulation of Morphine—Morphine ARER
2016
·
Lynn R. Webster
, Carmela Pantaleon
, et al.
·
Pain Medicine
·
17
Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration's recommendation for Category 1 Testing
2017
·
Christopher Altomare, BS
, Eric R. Kinzler, PhD
, et al.
·
Journal of Opioid Management
·
9
Effect of Ethanol on the Release of Morphine Sulfate From Oramorph SR Tablets
2009
·
Robert L Barkin
, Dean Shirazi
, et al.
·
American Journal of Therapeutics
·
9
Syringeability of morphine ARER, a novel, abuse-deterrent, extended-release morphine formulation
2019
·
Eric R. Kinzler
, Carmela Pantaleon
, et al.
·
The American Journal of Drug and Alcohol Abuse
·
8
Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects
2018
·
Lynn R. Webster
, Carmela Pantaleon
, et al.
·
Pain Research and Management
·
8
PDF
(404) Extraction testing of a novel extended-release, abuse-deterrent formulation of morphine, Morphine ARER, in common household solvents
2014
·
R. Bianchi
, E. Kinzler
, et al.
·
Journal of Pain
·
8
PDF
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent Formulation
2018
·
Lynn R Webster
, Matthew Iverson
, et al.
·
Pain Medicine
·
6
PDF
Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study
2019
·
Lynn R. Webster
, Eric R. Kinzler
, et al.
·
Advances in Therapy
·
3
PDF
(448) Practitioners knowledge, attitudes, and practices regarding opioid abuse deterrent formulations
2014
·
J. Pergolizzi
, R. Taylor
, et al.
·
Journal of Pain
·
2
In vitro evaluation of a novel immediate-release formulation of oxycodone (RoxyBond™) for the potential for abuse via injection
2020
·
Eric R. Kinzler, PhD
, Carmela Pantaleon, BS
, et al.
·
Journal of Opioid Management
·
1
A Randomized, Crossover Study on the Effect of Food on the Pharmacokinetic Characteristics of Morphine ARER (MorphaBond™ ER), an Abuse-Deterrent Formulation of Extended-Release Morphine
2019
·
Eric R. Kinzler
, Carmela Pantaleon
, et al.
·
Advances in Therapy
PDF
Relative Oral Bioavailability of an Abuse-deterrent, Extended-release Formulation of Morphine Versus Extended-release Morphine: A 2-period, Single-dose, Randomized Crossover Study in Healthy Subjects
2018
·
Eric R. Kinzler
, Carmela Pantaleon
, et al.
·
Clinical Therapeutics
PDF
(450) Abuse rates of oxycodone in the US: data from the RADARS System
2014
·
R. Taylor
, J. Pergolizzi
, et al.
·
Journal of Pain
(465) Trends and characteristics of individuals who abuse ER morphine: data from the RADARS System
2014
·
R. Raffa
, J. Pergolizzi
, et al.
·
Journal of Pain
A qualitative comparison of diclofenac potassium soft gelatin capsules (DPSGC, Zipsor®) to other analgesics in the treatment of acute pain following bunionectomy
2011
·
S. Daniels
, A. Rubin
, et al.
·
Journal of Pain
PDF
Show more works
View as search
Works count:
20
Citation count:
242
H-index:
8
I10-index:
4
Year
Topic
Type